miR‐885 mediated cardioprotection against hypoxia/reoxygenation‐induced apoptosis in human cardiomyocytes via inhibition of PTEN and BCL2L11 and modulation of AKT/mTOR signaling.

Ischemia/reperfusion (I/R) injury could cause the enhanced cell apoptosis of cardiomyocytes, which is one of key contributors for the development of ischemic heart disease. Recent studies emphasized the role of microRNAs (miRNAs) in regulating cardiomyocyte apoptosis. The study planned to elucidate the molecular actions of miR‐885 on mediating human cardiomyocytes (HCMs) apoptosis induced by hypoxia/reoxygenation (H/R) and to explore the potential molecular mechanisms. The present data revealed that H/R stimulation inhibited HCM viability and potentiated HCM apoptosis, and more importantly, the expression of miR‐885 in HCMs was markedly repressed after H/R stimulation. Further experimental examinations demonstrated that overexpression of miR‐885 attenuated H/R‐induced increased in HCM apoptotic rates, while miR‐885 knockdown impaired HCM viability and increased HCM apoptotic rates. Moreover, the mechanistic studies showed that miR‐885 inversely regulated the expression of phosphatase and tensin homolog (PTEN) and BCL2 like 11 (BCL2L11) in HCMs, and enforced expression of PTEN and BCL2L11 partially antagonized the protective actions of miR‐885 overexpression on H/R‐induced HCM injury. Moreover, H/R suppressed AKT/mTOR signaling, which was attenuated by miR‐885 overexpression in HCMs. In conclusion, the present study for the first time showed the downregulation of miR‐885 induced by H/R in HCMs, and provided the evidence that miR‐885 attenuated H/R‐induced cell apoptosis via inhibiting PTEN and BLC2L11 and modulation of AKT/mTOR signaling in HCMs. [ABSTRACT FROM AUTHOR]